Most of the information regarding how LRP1 dysfunction may increase metabolic disease risk is inferred from in vitro cell culture experiments or in vivo studies with conditional knockout mice with tissue-specific LRP1 deficiency. This evidence concerns the gene LRP1 and metabolic disease.